What You Should Know
New York Cancer & Blood Specialists (NYCBS) has partnered with Talkiatry to provide integrated, high-quality psychiatric care to oncology and hematology patients.The collaboration will roll out across more than 30 NYCBS locations throughout New York, ensuring patients can access mental health support as a core part of their treatment.Talkiatry’s network of over 300 board-certified psychiatrists will provide both in-person and virtual consultations, accepting most
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Flatiron Health and COA Study: Community Oncology Survival Rates Outperform SEER National Benchmarks
What You Should Know
Patients with metastatic breast cancer and non-small cell lung cancer (mNSCLC) treated in independent community oncology practices lived longer than national benchmarks.Median survival for metastatic breast cancer patients in community settings was eight months longer than the national SEER benchmark.For patients with mNSCLC, median survival in community practices was two months longer than national standards.The study analyzed real-world data from nearly 98,000 patients
Read More
UChicago Medicine Partners with Artisight to Deploy Smart Hospital Platform Across 1,800 Patient Rooms
What You Should Know
UChicago Medicine has signed an enterprise agreement to deploy Artisight’s Smart Hospital Platform, implementing more than 1,800 devices across its clinical enterprise.The rollout covers diverse care settings, including patient rooms, operating rooms, PACUs, and a new 575,000-square-foot freestanding cancer facility opening in April 2027.The platform utilizes computer vision, voice recognition, and RTLS (Real-Time Location Services) to automate documentation and support
Read More
FDA Announces Real-Time Clinical Trial Pilot Program and Proof-of-Concept Studies with AstraZeneca and Amgen
What You Should Know
The FDA has launched two proof-of-concept (PoC) real-time clinical trials (RTCT) that report endpoints and data signals to the agency as they occur.AstraZeneca is leading a Phase 2 trial (TRAVERSE) for mantle cell lymphoma, while Amgen is conducting a Phase 1b trial (STREAM-SCLC) for small cell lung carcinoma.The initiative aims to eliminate the traditional "hiatus" between clinical phases, moving toward a model of "continuous" trials that reduces regulatory lag.A Request
Read More
Beth Israel Lahey Health Partners with Heidi to Deploy Ambient AI Scribing to All Physicians
What You Should Know
Beth Israel Lahey Health (BILH) is expanding its partnership with Heidi to provide ambient AI scribing capabilities to all of its more than 6,000 providers.An initial 6-month trial involving 1,000 providers resulted in 89% satisfaction regarding the quality of generated medical notes.The technology significantly impacts clinician well-being, with 82% of trial users reporting reduced cognitive load and 74% noting a reduction in time spent working outside of standard
Read More
Koda Health Secures Investment from UPMC Enterprises for AI-Enhanced Advance Care Planning Platform
What You Should Know
The Investment: Koda Health secured a Series A strategic investment from UPMC Enterprises to aggressively scale its AI-enhanced Advance Care Planning (ACP) platform across complex patient populations.The Financial Toll: The American healthcare system currently spends an estimated $200 billion annually on care that patients would not have wanted had they been engaged in care planning earlier in their journey.The Technology Engine: The platform navigates patients through
Read More
Covera Health and Medmo Combine to Launch Nationwide AI Diagnostic Imaging and Care Coordination Platform
What You Should Know
Covera Health and Medmo have officially merged into a single organization, creating a unified platform that manages diagnostic imaging for nearly 6 million Americans.The combined entity is backed by additional capital from Insight Partners and serves major clients, including Walmart, Blue Cross Blue Shield of Michigan, and three of the five largest national health plans.Covera’s AI-driven platform focus on diagnostic accuracy has produced up to 12 percent lower downstream
Read More
FDA Clears Tandem Control-IQ+ for Type 1 Diabetes During Pregnancy: First AID System to Earn Indication
What You Should Know
The FDA has cleared Tandem’s Control-IQ+ technology for use in pregnancies complicated by type 1 diabetes, making it the first and only commercially available AID system with this indication in the U.S.The expanded label applies to both of Tandem’s delivery systems: the t:slim X2 and the Tandem Mobi.In the CIRCUIT trial, participants using Control-IQ+ spent 12.6% more time in the pregnancy-specific glucose target range (63-140 mg/dL) compared to those on standard
Read More
Auxira Health and St. Luke’s University Health Network Partner to Expand Virtual Cardiology Support
What You Should Know
St. Luke’s University Health Network (SLUHN) is collaborating with Auxira Health to integrate virtually-embedded teams into its Heart & Vascular network.The model provides each cardiologist with a virtual support team of nurse practitioners, medical assistants, and registered nurses to manage follow-ups and care coordination.The initiative launches with 24 cardiologists, with established plans to expand across multiple St. Luke’s locations in Pennsylvania and New
Read More
NEJM Catalyst Study Validates No Barrier’s Hybrid AI-Human Model for High-Stakes Surgical Communication
What You Should Know
No Barrier’s AI-powered medical interpretation platform was tested in an independent study at Mass General Brigham, published in the New England Journal of Medicine (NEJM) Catalyst.The research compared Remote Video Interpretation (RVI), No Barrier’s real-time AI, and a hybrid approach to assess patient preferences using a modified technology acceptance model (TAM).Findings indicate that RVI is preferred for emotionally sensitive or high-stakes surgical conversations,
Read More
